Clinical Trials Logo

Filter by:
NCT ID: NCT00882622 Withdrawn - Atrial Fibrillation Clinical Trials

Effect of Remote Ischemic Preconditioning on Cardiac Function After Cardiac Surgery

Start date: February 2009
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the effects of Remote Ischemic Preconditioning on cardiac function in patients undergoing cardiac surgery compared to control intervention.

NCT ID: NCT00876278 Withdrawn - Cataract Clinical Trials

Night Driving Pilot

Start date: June 2009
Phase: Phase 4
Study type: Interventional

Pilot study to evaluate usability of Mesotest II for assessment of night driving capacity of pseudo-phakic patients implanted with aspheric monofocal posterior chamber IOL *AT.Smart 46LC. Target Criterion: Measurement of contrast sensitivity and sensitivity to light under mesopic conditions (Mesotest II, Oculus).

NCT ID: NCT00869856 Withdrawn - Anemia Clinical Trials

Study to Evaluate the Efficacy, Safety and Immunogenicity of Subcutaneous HX575 in the Treatment of Anemia Associated With Chronic Kidney Disease (SWEEP)

SWEEP
Start date: April 2009
Phase: Phase 3
Study type: Interventional

This is an open-label, single-arm, baseline-controlled, multicenter efficacy and safety switch study involving 500 CKD subjects suffering from anemia and treated previously with a stable dose of ESA s.c. Correction of anemia will be maintained by s.c. administration of HX575 in two frequencies (i.e. qw and q2w), in order to maintain an Hb target range of 10.0-12.0 g/dL.

NCT ID: NCT00869102 Withdrawn - Diabetes Clinical Trials

Characterization of Beta Cell Failure

Start date: May 2009
Phase: N/A
Study type: Interventional

The purpose of this study is to characterise beta cell function in subjects who despite taking part in a diabetes prevention program (life style intervention with diet and exercise) exhibit impaired glucose tolerance and beta cell dysfunction.

NCT ID: NCT00868946 Withdrawn - Clinical trials for Hemorrhagic Fever With Renal Syndrome

Ribavirin for Hemorrhagic Fever With Renal Syndrome in Germany

HFRS
Start date: October 2009
Phase: Phase 2
Study type: Interventional

This is a treatment protocol using IND Ribavirin-there is no control group. Hemorrhagic Fever with Renal Syndrome (HFRS) is caused by a virus acquired by contact with chronically infected rodent hosts. HFRS is present throughout Europe and caused mainly by Puumala and Dobrava viruses. Treatment consists mainly of supportive care with careful attention to control of blood pressure and fluid balance and/or dialysis. Early initiation of IND Intravenous Ribavirin has been shown to be an effective treatment for HFRS and may prevent the need for dialysis. It is important to initiate therapy based on a diagnosis consistent with HFRS (determination if the disease is caused by Puumala or Dobrava virus is helpful) and a history that makes exposure likely. This study will monitor the clinical events that occur with HFRS as well as the safety and efficacy of Ribavirin.

NCT ID: NCT00835887 Withdrawn - Clinical trials for End Stage Renal Disease

Relevance of Flavanols for Cardiovascular Function in End-Stage Renal Disease

ESRD
Start date: n/a
Phase: Phase 2
Study type: Interventional

In this study, the acute and long-term effects of flavanols on vascular function in patients with ESRD will be investigated.

NCT ID: NCT00825331 Withdrawn - Clinical trials for Cardiac Catheterization

Improvement of Periprocedural Guidewire Management for Cardiac Catheterization (PTCA)

Start date: January 2009
Phase: N/A
Study type: Observational

Periprocedural management of guidewire placement and removal in patients needing cardiac catheterization by use of marking of the access site and removal procedure due to a graduated scheme

NCT ID: NCT00789165 Withdrawn - Arrhythmia Clinical Trials

Empiric Quinidine for Asymptomatic Brugada Syndrome

Start date: December 2009
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to determine if quinidine therapy (not guided by the results of electrophysiologic studies) will reduce the long-term risk of arrhythmic events in asymptomatic Brugada Syndrome.

NCT ID: NCT00771797 Withdrawn - Clinical trials for Peripheral Artery Disease

Peripheral Artery Occlusive Diseases (PAOD) Study - Clinical Assessment

Start date: October 2008
Phase: Phase 2
Study type: Interventional

To assess the clinical efficacy and to simultaneously explore the underlying molecular mechanisms of the beneficial effects of flavanol-rich cocoa on vascular function diabetic patients with peripheral artery occlusive diseases (PAOD) of the lower extremities will be investigated.

NCT ID: NCT00738517 Withdrawn - Heart Failure Clinical Trials

Immunoadsorption and Immunoglobulin Substitution for Heart Failure After Myocardial Infarction

Start date: September 2008
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to investigate, if immunoadsorption of autoantibodies with subsequent substitution of immunoglobulins is able to improve cardiac function of patients with heart failure after myocardial infarction and presence of cardiac autoantibodies.